MEMGEN, INC.

Profile

Company Names

MEMGEN, INC.
MEMGEN, LLC

Addresses

12 GREENWAY PLAZA, SUITE 1100, HOUSTON, TX 77046

Phone Numbers

8325485651

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$12,032,205.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-11-04 
$624,979.00 
$10,000,000.00 
$9,375,021.00 
Equity 
4
2021-11-30 
$9,767,223.00 
$10,000,000.00 
$232,777.00 
Equity 
3
2020-05-21 
$575,000.00 
$10,000,000.00 
$9,425,000.00 
Debt 
2
2019-09-10 
$350,000.00 
$5,000,000.00 
$4,650,000.00 
Equity 
1
2018-11-19 
$715,003.00 
$1,900,000.00 
$1,184,997.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
PATRICIA 
 
BITAR 
DIRECTOR
MEMGEN, LLC   |  MEMGEN, INC.
GREGORY 
 
BROWN 
DIRECTOR, EXECUTIVE OFFICER
EDGE HEALTH INITIATIVES, LLC   |  NURON BIOTECH, INC.   |  CHARLOTTE ANGEL FUND II, LLC   |  AQUESTIVE THERAPEUTICS, INC.   |  MEMGEN, LLC   |  MEMGEN, INC.   |  CURVEBEAM AI LTD   |  MATRIX CAPITAL MANAGEMENT FUND (OFFSHORE) LTD.
MARK 
 
CANTWELL 
EXECUTIVE OFFICER, DIRECTOR
MEMGEN, LLC   |  MEMGEN, INC.
ROBERT 
 
COATES 
EXECUTIVE OFFICER, DIRECTOR
MEMGEN, LLC   |  MEMGEN, INC.   |  ATOMIZER 28, A SERIES OF ATOMIZER LLC
KEVIN 
 
COVENEY 
EXECUTIVE OFFICER
MEMGEN, INC.   |  ENVERIC BIOSCIENCES, INC.
CASEY 
 
LOGAN 
DIRECTOR
ANAPHORE, INC.   |  MEMGEN, LLC   |  MEMGEN, INC.
CHRISTOPHER 
 
PAGANO 
DIRECTOR
ASSURANT INC   |  MEMGEN, LLC   |  MEMGEN, INC.
JOHN 
 
POULOS 
DIRECTOR
MEMGEN, INC.
STEVEN 
 
WHITLEY 
DIRECTOR
MEMGEN, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-06-30
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2022-11-17
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-04 
2021-12-14
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-30 
2021-12-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-11-30 
2020-07-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-21 
2020-07-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-21 
2020-06-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2020-05-21 
2019-09-23
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-10 
2018-12-04
D
Link
BIOTECHNOLOGY 
 
NO REVENUES 
Equity 
2018-11-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#